Clinical Trial Update: Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irofulven in combination with capecitabine for advanced thyroid cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irofulven (irofulven)

Snippet

Sponsor: Eisai Inc. | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED